Heart attack symptoms in women over 50

Not Just a "Broken Heart":
The Deadly Gap in Cardiac Care for Women 50plus

Introduction Welcome to the second instalment of my series exploring the Gendered Ageing Gap – a systemic failure where women over fifty are effectively ghosted by scientific research. We are living in a revolutionary age of Artificial Intelligence, yet we are still operating under a “male-as-default” medical model that was outdated when we were in bell-bottoms (yeah, I know, they are back…). If we want to avoid becoming a historical footnote in an LLM’s training data, we have to do two things: take fierce ownership of our own biological health and get aggressively involved in the digital world to ensure our reality is included in the algorithms. Because, as I’ve learned the hard way, the cost of being “invisible” isn’t just an annoyance – worst case, it’s lethal. The Personal Cost of “Atypical” Labels I recently lost my sister-in-law to this exact brand of medical neglect. She was five years younger than me – never smoked, stayed in reasonably good shape, and lit up every family gathering with that vibrant, steady presence you only fully appreciate when it’s gone. After years in a difficult marriage, she finally rebuilt her life: a divorce, then a partner who loved her well, daughters finding their way into happy marriages, and the arrival of grandchildren – an idea she used to laugh about as if it belonged to someone else’s story, not hers. Then, on a Friday afternoon, she ran into one of my nephews and mentioned she wasn’t feeling right. “I probably ate something wrong,” she said. “I’ll rest, and if it’s not better, I’ll see the doctor on Monday.” My nephew is an anaesthesiologist. He asked for an ECG – just to be safe. The tracing wasn’t normal, but it wasn’t dramatic either; nothing that screamed emergency. Still, she was rushed to hospital, and a heart attack was confirmed. She was treated quickly, yet the complications that so often follow women’s heart attacks hit with brutal speed. She was flown to a specialist clinic, endured eight hours of open-heart surgery, and died days later from multiple organ failure. She received good care. And still, she didn’t make it. She was healthy. She was reasonably fit. She was supposed to have decades left. But she fell into the “gender gap” of cardiac care – a gap that treats the female body as a physiological variant rather than a biological reality. The Gaslighting of the “Atypical” Symptom Physicians, particularly male providers, have a documented habit of under-considering cardiac risk factors in women. When we show up with symptoms that don’t look like a Hollywood movie, our distress is frequently attributed to anxiety, stress, or perhaps that spicy lunch we had. Or menopause, something many physicians don’t take seriously anyway. Nearly half of women do not present with the “typical” crushing chest pain seen in men. Let’s be clear: if half the population experiences a symptom, it isn’t “atypical.” It’s just “female”. Symptom Category Male Presentation (Standard) Female Presentation (The “Atypical” Reality) Primary Pain Crushing central chest pain Back, neck, or jaw pain Gastrointestinal Rare Nausea, indigestion, abdominal pain Respiratory Common dyspnoea Shortness of breath, unexplained fatigue Psychological Fear of death Malaise, dizziness, intense anxiety Table comparing male vs female heart attack symptoms – back pain, jaw pain, nausea in women Because our symptoms deviate from the male-centric standard, we are 50% more likely than men to receive an incorrect initial diagnosis. We aren’t just being ignored; we are being actively misdiagnosed into an early grave. I must admit, if I had symptoms like my sister-in-law, I wouldn’t bother asking for help – I’d just decide to wait until Monday… The 8,000 Avoidable Deaths This isn’t just a matter of “bad bedside manner.” It is a structural failure of our medical infrastructure. Because diagnostic protocols were developed using male data, women often receive fewer diagnostic tests, such as coronary angiography or cardiac enzyme assessments. Even when we are hospitalised, we are less likely to receive coronary interventions or be referred to cardiac rehabilitation. Surprisingly, even if they do show the same symptoms as men, this happens. The result? In England and Wales alone, differences in care contributed to an estimated 8,000 avoidable deaths over a decade. Other countries show similar results, and it is heartbreaking, literally: These were women who were “not done yet.” These were sisters, mothers, and colleagues who were written off by a system that couldn’t be bothered to look at the data. Regardless of the country, medical experts emphasise that women must regularly advocate more strongly for themselves, as healthcare providers are still statistically less likely to attribute atypical symptoms to heart disease in female patients. But even if women show typical symptoms, they do not get the necessary care right away – the heart attack gender gap. AI and the Scaling of Bias As we move into the age of AI-driven insights, the risk is that we automate this neglect. If we don’t get involved and ensure that LLMs and “Digital Patient Twins” are trained on representative data, these algorithms will simply generate “male-default” recommendations at scale. Currently, some diagnostic AI models are using demographic “shortcuts” like age and gender instead of clinical data. This is how we end up with “gendered ageism” in recruitment, too – where research shows LLMs consistently weave younger work histories into female profiles, viewing our value as declining while men are seen as “seasoned”. If we don’t have the health support to maintain our physical strength, and we don’t have the digital representation to protect our careers, we are being pushed out of the economy by a system that doesn’t understand our biology. Taking the Reins (Because the System Won’t) So, what do we do? We become the “myth-busters” of our own lives. We refuse to accept “anxiety” as a diagnosis for physical distress until every cardiac possibility has been exhausted. We demand the tests – the ECGs, the troponin levels – that the protocols might “forget” to order for a woman. We…

women over 50 / women 50 plus health

Why women aged 50-plus are still under-researched—clinically, nutritionally, and now algorithmically
The Women’s Health Research Gap: Tea, Trials, and the Trouble with “Male as Default”

Introduction This white paper began, as many questionable decisions do, with curiosity and the firm belief that “surely someone has already put all of this together”. “This” meaning a gender gap in research – especially when it comes to women aged 50 and 60-plus, or Generation Jones. I often feel we are excluded when I analyse the latest studies. And I was right: the research community had not looked into this in the way I expected – or at least not in one place, with the data, the sources, and the inconvenient details that tend to get quietly skipped. Over time, while writing blog articles on the subject, a pattern emerged: important parts were missing. Not the sort you can ignore with a polite cough, but rather large gaps – the kind you could lose a small car in. Given that the topic wanders across several areas of expertise, this is perhaps understandable. Still, to me, it was mildly irritating. The result is this document. It contains the numbers, the references, and the original sources. It also contains very little in the way of narrative excitement. This is not a page-turner. No one will stay up late reading it with a cup of tea, whispering, “Just one more section.” It is, unapologetically, thorough. Think of this white paper as the sensible friend: dependable, accurate, slightly dull at dinner parties, but exactly who you want when facts matter. It exists so you can check claims, follow the trail back to the source, and avoid saying something confident and wrong in public. Because not everyone wishes to spend their leisure time reading footnotes, the material has been broken down into a series of shorter articles. These are the chatty ones. Each focuses on a specific topic and aims to leave you thinking, “Right then. I understand this now, and I know what to do next.” As those articles are published over the coming weeks, they will be linked here in the introduction. Start there if you like. Come back here when you want the evidence. And if, at any point, this document feels a bit serious, just imagine two British ladies exchanging looks over their teacups and agreeing that, yes, it’s terribly dry – but rather useful. OK, so what is this about? The human longevity landscape presents a persistent biological and sociological enigma: while women consistently outlive men, they spend a significantly higher proportion of their lives in poor health, a phenomenon often described as the male–female health-survival paradox. [1, 2, 3] This discrepancy is not merely a by-product of intrinsic biological ageing but is profoundly exacerbated by a historical and systemic neglect of women aged 50 and older in scientific research. [2, 4, 5] For decades, medical and nutritional sciences have operated under an androcentric, or “male-as-default” (yes, I had to look this one up), model, wherein the female body is treated as a physiological variant of the male standard, often framed as a complication due to hormonal fluctuations and reproductive cycles. [6, 7] As women cross the threshold of 50 – a period typically defined by the pivotal transition of menopause – they enter a “research desert” in which their specific physiological, nutritional, and technological needs are frequently ignored or misattributed. [8, 9, 10] This report examines the multifaceted extent of this neglect across four critical domains: clinical health, nutritional science, longevity research, and the emerging field of artificial intelligence. By synthesising current data on clinical trial participation, metabolic shifts, evolutionary biology, and algorithmic bias, the analysis shows that the neglect of women over 50 is a structural failure that compromises the efficacy of modern medicine and the promise of healthy ageing. [4, 7, 11, 12] Structural Invisibility in Clinical Research and Medical Trials The underrepresentation of women in clinical trials is a legacy of protectionist policies that effectively institutionalized sex bias in medical research.[13, 14] Between 1977 and 1993, the United States Food and Drug Administration (FDA) implemented guidelines that excluded women of “childbearing potential” from early-phase clinical research to prevent potential fetal harm, a policy that was broadly applied and essentially excluded the majority of women from medical research for nearly two decades.[6, 13, 14] Although the NIH Revitalization Act of 1993 mandated the inclusion of women, the scientific community has struggled to rectify the resulting data gap, particularly for older women who fall outside the traditional reproductive window.[6, 13, 15] The Age-Sex Enrolment Gradient Recent systematic reviews and meta-analyses highlight a concerning trend: as the average age of clinical trial participants increases, the proportion of female enrolment decreases.[16] While the median enrolment rate for women across all fields is approximately 41%, this figure is not static across age groups.[16] Average Age of Trial Participants Median Enrolment Rate of Women Statistical Significance (p-value) ≤ 45 years 47% (IQR 30–64) p < 0.001 [16] 46–55 years 46% (IQR 33–58) p < 0.001 [16] 56–62 years 38% (IQR 27–50) p < 0.001 [16] ≥ 63 years 33% (IQR 20–46) p < 0.001 [16] This gradient demonstrates that women over 50 face a “double burden” of exclusion based on both sex and age. The reduction in participation for women aged 63 and older to just 33% creates a critical knowledge deficit regarding the benefit-risk profiles of treatments in a demographic that is often the primary consumer of these medical interventions.[11, 16] This exclusion is frequently justified by researchers through eligibility criteria that prioritize “organ-system abnormalities” or “functional status limitations,” which disproportionately filter out older women who may have co-morbidities.[17] Estimates suggest that relaxing these arbitrary restrictions could increase the participation of elderly adults in cancer trials from 32% to nearly 60%.[17] Disparities in Disease-Specific Representation The neglect of women 50 plus is particularly acute in fields where they bear a high disease burden, such as cardiology and oncology. [5, 18, 19] Cardiovascular disease (CVD) remains the leading cause of death for women, yet women continue to be under-represented and understudied in CVD clinical trials. [19, 20, 21] Historically, CVD…

Menopause Gold Rush and supplements for women 50plus

The Menopause Gold Rush: Are Your Supplements Help, Hype, or Hazard?

1. Introduction: Welcome to the Menopause Gold Rush If you have spent any time scrolling through your social media feed lately, you have likely noticed a distinct aesthetic shift. Gone are the days of generic, brown apothecary bottles tucked away in the back of a health food store. They have been replaced by a relentless parade of “shelf-ready” supplement brands featuring minimalist pastel packaging, celebrity endorsements, and sans-serif fonts that practically whisper “self-care.” This is the Menopause Gold Rush – the sudden and aggressive monetization of midlife. As women of Generation Jones – those of us born in the late 50s and early 60s – we are currently the primary target of this billion-dollar industry. The marketing is clever. It targets the very real suffering we face: the night sweats that leave the sheets damp, the “brain fog” that makes us forget why we walked into a room, and the quiet anxiety of watching our bone density reports slide in the wrong direction. I am not even talking about aching joints, back pain and a subtle loss of strength. We are being sold a promise that midlife can be “optimized” with a gummy, but the reality of hormonal shifts is far more complex than a peach-flavoured chew can solve. At a cellular level, our bodies are undergoing a massive transition. Our telomeres – the protective caps on our chromosomes – are shortening. Our “zombie cells” (senescent cells) are accumulating, pumping out inflammatory signals that drive everything from joint pain to cardiovascular risk. In this environment, we need to be technical researchers of our own health, not just “influenced” consumers. We need to distinguish between the tools that support longevity and the flashy packaging that merely drains our bank accounts. “Consistency over miracles: In midlife, a single high-quality habit – grounded in evidence – beats a dozen trendy, unproven pills.” This article serves as your evidence-based filter. We will dive into the clinical reality of what our bodies actually need, deconstruct the marketing loopholes designed to trick us, and look at the sobering hazards hidden in the “natural” wellness aisle. Click here if you prefer to watch this content as a video. 2. Why We Are Tempted: The Gap in Midlife Care To understand why we are so susceptible to the Menopause Gold Rush, we have to look at the current state of healthcare for women over 50. Imagine the typical scenario: You book an appointment for unexplained fatigue and joint pain. You wait three weeks for a fifteen-minute slot (if you get indeed 15 minutes… Every so often I am in and out in 5 minutes). When you finally see the doctor, you’re often met with a shrug and a variation of, “Well, you are getting older; it’s just part of the transition.” Hell, I know that! But what can I do? This feeling of being dismissed or “aged out” by traditional medicine has created a massive void. When the white coat doesn’t have answers – or time – the “smart friend” on Instagram does. Influencers speak the language of empathy, validating our struggles before pivoting to a discount code. This has birthed a “DIY” health culture where women are forced to become their own primary care providers. We reach for supplements because we want to regain control. As estrogen declines, our metabolism shifts, our muscle mass begins to waste away (sarcopenia), and our bones become porous. The supplement industry knows this. They use keywords like “menopause supplements” and “women’s health after 50” to hook into our biological anxieties. But before we hit “Subscribe,” we must remember that we are playing the long game. We aren’t just trying to survive a hot flash; we are trying to extend our “Healthspan” – the number of years we live in vibrant, functional health. 3. The Good: Evidence-Based Support for the Long Game While I am deeply sceptical of the “miracle in a bottle” narrative, the science is clear: our nutrient needs change after 50. The National Institute on Aging (NIA) and modern longevity research highlight specific compounds that act as structural pillars for an aging body. These aren’t flashy, but they are essential. But before I go any further, improve your diet and lifestyle first, before diving into supplements – that way, you will not waste money on the industry, which just wants to fill their pockets with the Menopause Gold Rush. The Essentials List for Women 50+ Nutrient Proven Benefit Target Dosage for 50+ Calcium Prevents bone fractures; skeletal integrity. 1,200 mg per day (total from food/supps). Vitamin D Calcium absorption; immune/muscle health. 600–800 IU (up to 4,000 IU max). Under ideal conditions, exposing a large area of skin to the sun can produce 10,000 to 25,000 IU Vitamin B12 Nerve health; red blood cell formation. 2.4 mcg per day (methylcobalamin form). Creatine Muscle strength, cognition, and bone support. 5 g (standard micronized monohydrate). Omega-3s Lowers inflammation and heart & brain health. 1,000 mg+ (Prioritize high EPA/DHA). Magnesium Muscle relaxation, sleep & nervous system. 310–320 mg (citrate or Glycinate). The Technical Frontier: Metabolic Pathways and Longevity While vitamins and minerals provide the foundation, the true frontier of midlife health lies in metabolic signaling pathways. As women of Generation Jones, we aren’t just looking to avoid deficiencies; we are looking to influence how our cells age at a fundamental level. The Energy Switch: AMPK and Actiponin One of the most critical regulators of our metabolism is AMPK (adenosine monophosphate-activated protein kinase), often called the “metabolic master switch”. When activated, AMPK shifts the body into fat-burning mode and initiates “autophagy” – a cellular cleanup process that removes damaged components. The DNA Repair Engine: NR and NAD+ Every cell in your body relies on a molecule called NAD+ for DNA repair and energy production. Unfortunately, our NAD+ levels “crash” as we transition through menopause. The Longevity Tool: Supplementing with precursors like Nicotinamide Riboside (NR) is currently considered one of the most promising ways to support cellular survival and metabolic health in our 50s. Deep Dive:…

Does intermittent fasting work after menopause

Intermittent Fasting for Women Over 50: Risks, Benefits, and the “Gen Jones” Guide

The Midlife Reality Check: Why Menopause Changes Everything “Intermittent fasting is not wrong. It’s just often applied at the wrong time, for the wrong goal, by the wrong people.” If you’ve spent any time on social media lately, you’ve likely encountered her: a 34-year-old “wellness alchemist” standing in a sun-drenched, white-marble kitchen, claiming that a 20-hour fast is the secret to her “glow.” It’s a lovely aesthetic, but for those of us navigating the physiological landscape of ages 55 –65, that advice is about as useful as a screen door on a submarine. While the “Pinterest-perfect” lifestyle suggests that extreme restriction is the ultimate bio hack, the reality of intermittent fasting for women over 50 and 60 (the group with the label “Generation Jones”) is far more nuanced. We aren’t just smaller versions of men, nor are we biologically identical to our 20-year-old selves. Our hormones have shifted, our muscle mass is under siege, and recent 2024 cardiovascular data suggest that what works for an influencer might actually be a liability for a post-menopausal woman. The purpose of this article is to move past the anecdotes and translate recent scientific research – including the latest metabolic and cardiovascular data – into a safe, practical guide for midlife health. What is Intermittent Fasting? 16:8 vs. 14:10 Methods Explained Intermittent Fasting (IF), often referred to in clinical literature as time restricted eating for older women, isn’t a “diet” in the traditional sense. It doesn’t dictate what you should eat, but rather when you should eat. This also means: if you eat unhealthy or simply too much, it doesn’t matter, whether you do this in 8 hours or spread over a longer time period. It is a pattern of cycling between periods of eating and fasting to trigger metabolic shifts. In this article and the underlying research, three primary methods are most commonly studied: Why Intermittent Fasting Feels Different After 50 Biology undergoes a seismic shift once we cross the threshold of menopause. But if you are in this age group, you certainly know this. The decline in estrogen – the hormone that previously helped regulate our insulin sensitivity and fat distribution – leads to a slower metabolism and an increase in visceral fat (the dangerous fat stored around your organs and is nicely called “muffin top”). This shift makes intermittent fasting after menopause an attractive prospect for weight management, but there is a significant catch: “anabolic resistance.” As noted in the Morton study, our bodies become less efficient at processing protein and stimulating muscle growth as we age. In fact, the effectiveness of protein supplementation actually decreases with age, meaning we face an uphill battle to maintain our metabolic engine. In other words, and to re-emphasize:  not just that supplementation effectiveness decreases, but that the threshold of protein needed to trigger muscle synthesis increases. Consequently, intermittent fasting and menopause can be a double-edged sword; while you may be trying to lose visceral fat, you might inadvertently accelerate the loss of the very muscle mass that keeps your metabolism humming. What the Research Says: The Hard Data Recent scientific reports provide a sobering look at how IF impacts the older female body. Here is the breakdown of the data: Benefits and Risks of Intermittent Fasting in Older Women When weighing the intermittent fasting benefits and risks, it is essential to look at the full picture of midlife health. Evidence-Based Intermittent Fasting Checklist for Women, 55–65 Potential Benefits Potential Risks Weight Management: Reduction in visceral (belly) fat and BMI when combined with exercise. Sarcopenia: Accelerated muscle loss due to “anabolic resistance” and poor protein timing. Insulin Sensitivity: 53% reduction in HOMA-IR (insulin resistance) in at-risk subjects. Bone Density Loss: Risk of mineral loss (observed in rat models) if nutrient intake is inadequate. Brain Health: Potential increase in BDNF, a protein that supports cognitive function and fights “brain fog.” Cardiovascular Risk: Preliminary 91% higher risk of CVD death associated with strict 8-hour windows (AHA 2024). Metabolic Health: Improved glucose markers and potential reductions in blood pressure. Nutrient Deficiencies: Difficulty hitting calcium, fiber, and D3 targets in short eating windows. Why Influencer Advice Often Misses the Mark The “more is better” ethos of the biohacking world – where 20-hour fasts are worn like badges of honour – is fundamentally mismatched with the biology of a woman over 50. Influencers often ignore the Morton et al. findings on the protein synthesis ceiling for ageing bodies: there is a “ceiling” to how much protein your body can use for muscle synthesis at once (~1.6g/kg/day). If you cram all your food into a tiny window, you physically cannot absorb the protein required to combat age-related muscle loss. What works for a 25-year-old with peak estrogen is metabolic sabotage for a woman in post-menopause. At 60, our biology has changed; we have to play by a different set of rules that prioritize preservation over deprivation. See the video I generated, based on the research. This explains it in a very easy-to-understand way. The Best Intermittent Fasting Schedule for Women Over 50 Based on the synthesis of NCOA and Morton reports, the best schedule isn’t an extreme one. It’s a “Pro-Aging Protocol” that prioritizes muscle: This is very much in line of how I structure my “Master Longevity@50plus” course: practical protein targets, smart strength training, and gentle fasting windows. I wouldn’t even call it fasting, rather taking a break from eating. No gimmicks, no “eat only in this corner of your kitchen,” no complicated rituals. Just simple, evidence-aligned steps you can stick with for years -without feeling miserable The Verdict: Is Intermittent Fasting Safe Over 50? So, is intermittent fasting safe for older women? Yes, but only if it is personalized and cleared by a doctor. While it can dramatically improve metabolic markers and insulin resistance, it is not a one-size-fits-all miracle. It must be approached with caution, especially for those with existing heart conditions or a history of disordered eating. Trust me, I know what I am talking about.…

AI in Medicine & Longevity: From Sick Care to a Smarter Second Act

For most of our lives, healthcare has been something we engage with reluctantly and episodically. You get sick, you see a doctor, you hope for the best. In between, you try not to think about it too much. But what if healthcare didn’t wait for you to fail first? What if, instead of reacting to illness, it quietly worked alongside you every day – analysing patterns, flagging risks early, supporting better decisions, and helping you stay healthy, independent, and functional for as long as possible? That question sits at the heart of one of the most profound shifts happening right now at the intersection of AI, medicine, and longevity. And contrary to popular belief, this shift is not happening somewhere in a distant, overfunded research lab. It’s already underway – messy, imperfect, and sometimes controversial – but very real. I live in Germany, where healthcare costs keep rising while access becomes harder. Finding a general practitioner who still accepts new patients can feel like winning the lottery. Specialist appointments often involve months of waiting. Emergency rooms are overloaded with people who don’t belong there but have nowhere else to go. In that context, the idea of a personal AI health assistant doesn’t sound futuristic. It sounds… necessary. Not as a replacement for doctors – but as a way to move healthcare away from reactive sick care and toward something smarter, more preventative, and more humane. Demystifying the “AI Doctor”: What Are We Actually Talking About? When people hear AI in medicine, many still imagine a cold, autonomous machine making life-and-death decisions behind a screen. That image is both inaccurate and unhelpful. A more realistic way to think about today’s medical AI is this: Imagine an exceptionally well-read intern. This intern has read nearly every medical textbook, research paper, guideline, and clinical trial ever published. It can process enormous amounts of information in seconds and reason across it in ways no human ever could. But – like any intern – it lacks lived experience, emotional intelligence, moral judgment, and responsibility. It doesn’t replace clinicians. It augments them. And increasingly, it also augments patients. This matters because medicine today is drowning in information. No physician – no matter how skilled – can keep up with the exponential growth of medical data, let alone integrate genetics, imaging, lab trends, lifestyle data, and emerging research into a coherent, personalised picture for every patient. But guess what: AI can. That doesn’t make it infallible. These systems can still produce errors or confidently wrong answers – often referred to as hallucinations. Even advanced models have measurable error rates. Even if those are reduced, there is the issue of model collapse. Which is precisely why human oversight, critical thinking, and informed patients remain essential. But something interesting is happening beneath the surface. In certain tasks, particularly pattern-heavy diagnostic work, AI is already performing at – and sometimes beyond – expert level. That doesn’t mean humans are obsolete. It means the division of labour is changing. How People Are Actually Using AI – and Why That Matters for Health One of the most surprising developments of the past two years has not been how doctors use AI, but how ordinary people do. The most common real-world uses of AI today are not technical or productivity driven. They are deeply human: These uses blur the line between “tool” and “partner.” And they set the stage for one of the most unexpected findings in medical AI research: patients often perceive AI communication as more empathetic than rushed human interactions. When did your doctor ever tell you: “Take a deep breath – and I am here, whenever you need me”. (I would be rather confused and concerned, if he would say that) That doesn’t mean machines feel empathy. It means they have learned the language of it – and that tells us something uncomfortable about how overstretched our healthcare systems have become. From the Lab to the Clinic: Where AI Is Already Changing Medicine AI is no longer confined to academic papers. It is already reshaping everyday clinical practice – sometimes quietly, sometimes controversially. Smarter Medical Imaging Pattern recognition is one of AI’s greatest strengths. In radiology, this matters enormously. Large studies have shown that AI systems can flag subtle abnormalities in imaging data that are easily missed by tired human eyes. In breast cancer screening, for example, AI-supported workflows have detected significantly more clinically relevant cancers while reducing the time radiologists spend reading scans. A radiologist friend once put it bluntly: “By mid-afternoon, my concentration slips. The fear isn’t that I don’t know what to look for – it’s that I might miss something small because I’m human.” AI doesn’t get tired. It doesn’t lose focus. And it doesn’t need coffee. Humans still make the final call – but they do so with better information and less cognitive strain. Reducing Administrative Burnout Another quiet revolution is happening behind the scenes: ambient AI documentation. These systems listen to doctor-patient conversations and generate structured clinical notes automatically. In theory, this frees physicians from the keyboard and restores eye contact, listening, and presence. In practice, success depends heavily on implementation, data protection, and workflow design. AI cannot compensate for bureaucratic excess. But used wisely, it can remove some of the worst administrative friction that drives burnout and early retirement. And burnout matters – because exhausted doctors make worse decisions. Or even leave the job. The Empathy Paradox Here’s where things get uncomfortable. Across multiple studies, patients rate AI-generated responses as more empathetic, more thorough, and more satisfying than those written by human clinicians – especially in text-based interactions. The reason is simple: This doesn’t mean AI should replace human connection. It means we should ask why humans are so often denied the time and space to provide it. A Personal Interlude: AI, Stress, and Mental Resilience By late 2025, I didn’t need studies to convince me of AI’s value in mental resilience. That year brought a perfect storm: the loss of my…

Science Based Longevity for women 50plus

Longevity for Women Over 50: Science, Menopause & Myths

Why Longevity Advice Fails Women After Menopause If you’d rather watch and listen than read yet another wall of text, this video at the bottom of this page is for you. It walks through the “longevity gender gap”, when you are on the go or forgot your reading glasses. Welcome to the longevity revolution, where buzzwords are flying faster than your Peloton can buffer. You can’t scroll through your feed without seeing ads for supplements that boost your sirtuins, optimize your NAD+, or reverse ageing with a dash of resveratrol. At least, that’s what started showing up in my timeline – and I thought: WTF?Because this narrative makes very little sense when you work with women 50+, many of whom are either on a hormonal rollercoaster or have just “survived” menopause. So, should we believe this dazzling – and dizzying – market promising to turn back the clock?Or stick to “conventional” tools with a proven track record? If yes, what are these? Here’s the billion-dollar secret they’re not telling you: most longevity advice is still built on a one-size-fits-all model, largely based on male biology, and it entirely ignores the dramatic (in my experience…) biological shifts women experience – especially before, during and after menopause. The truth is simple: this blueprint for male ageing does not translate well to women.The hormonal earthquake of menopause rewires female biology in ways that demand a different strategy for a long, healthy life. This article is your guide through the maze. I’ll cut through the marketing hype, examine the real science behind how men and women age differently, and highlight evidence-based strategies that actually make sense for women.It’s time to get savvy about ageing. How Men and Women Age Differently – The Biology Longevity Marketing Ignores In longevity science, one of the most crucial – and consistently overlooked – factors is sex. Men and women age along fundamentally different biological tracks. Understanding this divide is the first step toward a truly personalized approach to healthy ageing. I’ve spent time collecting trusted, high-quality studies and used NotebookLM to create an infographic that summarizes these differences in one overview.Admittedly, it’s not that simple – women are biologically complex – but I still like this image. Menopause and Estradiol: The Central Driver of Female Ageing For women, one of the most pivotal events is the marked suppression of estradiol synthesis during menopause. If you want a refresher on how hormones affect body composition and metabolism, my blog article Menopause Mystery – Hormones and Weight Gain covers the basics. Before menopause, estradiol acts as a powerful protector of multiple systems, including the nervous system, cardiovascular health, bones, and joints. In addition, it keeps stress hormones in line, a fact that plays an important role when dealing with menopause issues. Its decline leaves the body vulnerable in ways that are unique to female biology. Male Longevity Models and the mTOR Pathway Contrast this with a leading theory of male ageing: the mTOR (mammalian target of rapamycin) hypothesis. This theory suggests that chronic over-activation of the mTOR pathway promotes muscle growth and high testosterone in early life – but accelerates ageing and age-related disease later on. Sirtuins and Ageing: Why Patterns Differ in Men and Women This biological divergence also shows up in sirtuins, a family of proteins (SIRT1, SIRT3, SIRT6) involved in cellular resilience. A fascinating study of an Azerbaijani longevity cohort revealed distinct patterns: The implication is clear: longevity strategies built around male ageing models will always be incomplete for women. Longevity Supplements Under the Microscope – What the Science Really Says The longevity market is booming with “miracle molecules” and “breakthrough supplements.”If you’ve read more of my work, you know I have a well-calibrated BS radar. Before jumping on any bandwagon, we need scepticism – and solid evidence. Sirtuins and Resveratrol – Longevity Breakthrough or Marketing Myth? Early studies in yeast suggested that the gene SIR2 (and its human equivalent SIRT1) might be a longevity gene. Excitement followed – along with framing bias, confirmation bias, and a generous helping of hype. One more reading recommendation to understand the confusing world of nutritional studies: “How to decode nutritional studies – without losing your mind” Today, many researchers consider the case for sirtuins as dominant longevity genes to be weak. The Resveratrol Myth No supplement has been more closely linked to sirtuins than resveratrol – and none more overhyped. We now know that: (If you enjoy myth-busting: my free e-book Busting Myths and Boosting Health covers this in detail – the “Red Vine Saga” included.) NAD+ Supplements – Benefits, Risks, and Missing Evidence NAD+ (Nicotinamide Adenine Dinucleotide) is essential for cellular energy metabolism and DNA repair, and levels do decline with age – particularly in skin. This has triggered a marketing gold rush for NAD+ precursors like nicotinamide riboside (NR). Unfortunately, the hype has outrun the data: Evidence-Based Longevity Strategies for Women Over 50 Instead of chasing expensive trends, let’s focus on strategies that are evidence-based, safer, and particularly relevant for women over 50. The Estradiol–SIRT1 Axis: Women’s Built-In Longevity Pathway One of the most powerful – and overlooked – pathways in female biology is the estradiol–SIRT1 axis. Estradiol modulates SIRT1 expression and activity in the brain, cardiovascular system, bones, muscles, and liver. When menopause disrupts this axis, cellular resilience suffers. Hormone Replacement Therapy (HRT): Timing, Risks, and Benefits This is one reason why hormone replacement therapy (HRT) can be beneficial for some women. Evidence suggests that: HRT is a medical decision with individual risks and benefits. This information is educational – not prescriptive. Always discuss options with a qualified healthcare provider, who is familiar with the topic and who listens to you. I have used HRT for many years, after careful assessment of risks and benefits. And if my gynaecologist would recommend taking it again – I would do it. Exercise and Nutrition – The Most Powerful Longevity Tools for Postmenopausal Women When the marketing noise fades and the molecular magic tricks are set aside, longevity becomes…

Longevity Economy

Smarter, Longer, Safer: How Responsible AI Can Unlock the True Potential of the Longevity Economy

Discover how Responsible AI can unlock high-value opportunities in the rapidly growing Longevity Economy. This article explores underutilized AI niches – from financial protection to adaptive accessibility and purpose-driven engagement-that can transform AI-supported longevity for adults 50+. I.  Executive Summary: Strategic Opportunities in AgeTech AI The rapid demographic shift toward an ageing global population presents an unprecedented market opportunity, widely referred to as the Longevity Economy. I admit, for many years, the phrase “ageing population” sent shivers down my spine. Well, today I am part of that group and, thanks god, I am not alone: by 2050, the global number of individuals aged 60 and over is projected to double, reaching 2.1 billion.[1] This demographic transformation coincides with an ongoing digital revolution: adults aged 50-plus have rapidly integrated digital services into their daily lives, achieving near parity with younger adults in device ownership and basic digital fluency.[2] The Longevity Economy already represents a multi-trillion-dollar force, characterized by higher per-capita spending and status as the fastest-growing consumer segment globally.[3] However, this high level of digital engagement creates an adoption paradox. While older adults embrace mainstream technology, the utilization of advanced AI remains shallow. Adoption is currently concentrated in reactive care solutions – fall detection, medication reminders, and generalized virtual companionship (see my previous article: Longevity 2.0 – AI and Ageing for Women 50plus) – a segment rapidly approaching competitive saturation.[4, 5] In addition, “reactive care” is a concept aimed at age groups that are already affected by impairments. In plain English: people who are older than I. Deeper adoption is constrained by legitimate concerns over privacy, data security, algorithmic bias, and poor user experience that often imposes excessive cognitive load. [6, 7, 8]. Furthermore, I see another issue: many companies are jumping on the AI hype without a clear plan for how revenue will actually be generated. Since most tech companies are led by relatively young people, predominantly male, issues related to ageing may simply not be a priority for them. Strategic investment in AI-supported longevity must therefore pivot from basic, reactive care to complex, high-stakes enablement tailored to the economic, cognitive, and emotional realities of the 50-plus demographic. For this paper, I have identified three underutilized AI market niches defined by complexity, high emotional value, and a critical requirement for Responsible AI and explainable AI (XAI) architectures: These niches demand solutions that move beyond simple consumer tools to form trustworthy, infrastructure-level components of the Longevity Economy. I know this sounds boring. But trust me, once you reach a certain age, it suddenly becomes very relevant. II. The Current AgeTech Landscape: Establishing the Utilization Baseline 2.1 Digital Parity and Economic Scale Any serious strategy for AgeTech and AI-supported longevity must start from a realistic view of digital capability. Device ownership among older adults now rivals that of younger generations; smartphone ownership, for example, increased from 55% in 2016 to 90% by 2025.[2] This group is fully engaged in complex digital activities, including online banking, streaming, e-commerce, telehealth, and digital navigation.[2] Texting has even become the leading communication method for adults aged 50-plus.[2] I am in this age group myself, and while my work has “forced” me to stay ahead of the curve, I regularly observe people older than I am using their smartphones with ease and confidence. This high digital fluency makes one thing clear: reluctance to adopt sophisticated AI is not due to basic digital illiteracy. Instead, it reflects specific technological, ethical, and trust deficits in current offerings. I share many of these concerns, as I outlined in another article: The Amplifier and the Mirror: Why AI won’t save us. From a market perspective, the implications for the Longevity Economy are substantial. As this segment grows, [3] demand is rising for high-value AI services that genuinely enhance autonomy and security, rather than watered-down consumer tech. Increased engagement with high-stakes online activities – financial management, investing, and health data sharing [2] – also expands the attack surface for fraud and abuse. Generative AI is already accelerating the sophistication of fraud tactics, including convincing social engineering and deepfakes. [9, 10] The rate of exposure and potential financial loss is outpacing the availability of specialized, Responsible AI defence mechanisms targeted at this demographic. As longs as the risk is so high, many people, no matter how old, are reluctant to make use of AI. In other words: there is a high-priority opportunity for AI-driven digital guardianship in general, and within the Longevity Economy it becomes even more important. Regulatory environments add another layer. While the EU has implemented a comprehensive, risk-based AI framework (EU AI Act) emphasizing human rights and high-risk systems, the U.S. approach remains fragmented, with sector-specific rules and state laws (such as Colorado) but no federal AI legislation. Instead, it advances a “trustworthy AI” National AI Strategy and rather seems to protect big AI corporations. Across both contexts, there is a clear need: Responsible AI systems designed specifically for older adults, with transparent safeguards that match the complexity of modern digital life. 2.2 Saturation Mapping of Utilized Segments The current AgeTech AI market is dominated by offerings addressing immediate physical safety and basic emotional needs. Several areas are already crowded: Remote Monitoring and Safety: Fall detection, medication management, and remote vital monitoring.[4] Major players include IBM, Koninklijke Philips, and specialized companies such as CarePredict and InteliCare.[5] Basic Companionship: Systems like ElliQ and Dialzara provide conversational interaction, scheduling, and simple health tracking.[11] Their primary aim is to reduce isolation and support routine self-management.[12] Workflow Optimization: On the provider side, AI is used to improve staff workflows and operational efficiency in elderly care settings. [4, 13] The strategic gap lies in moving from reactive to predictive and proactive approaches. While around 70% of older Americans manage chronic health conditions,[14] few widely adopted AI systems integrate multimodal data to forecast acute health episodes, optimize complex chronic disease protocols, or support nuanced decision-making. Or, even better, support a healthy lifestyle, that prevents chronic diseases in the first place. For a sophisticated Longevity Economy, this…

Why AI won’t save us or responsible AI

The Amplifier and the Mirror: Why AI Won’t Save Us

…..and How We Can Save Ourselves Based on conversations with economists and AI specialists, this essay looks at what AI can really do for society – and where I see its limits. I’ve come to believe that our future depends far more on human integrity, education, and our collective will than on any machine. Keyword: Responsible AI. I share what I’ve observed, what a careful analysis reveals, and where I stand. But of course, I’d love to hear your perspective. Beyond the Hype – A Sober Look at the AI Revolution Let’s be honest: artificial intelligence has become the new religion of progress.We are told it will cure cancer, reverse climate change, run our companies, and maybe even fix our marriages if we ask politely enough. Every conference stage, TED Talk, and LinkedIn post seems to promise salvation through algorithms. And yet, beneath all this digital euphoria runs a deep unease.Will AI take our jobs? Entrench inequality? Decide who gets healthcare or a mortgage?Or worse: is there a risk, that it will quietly make us irrelevant? After years of observing this debate – from the front row of academia and the trenches of corporate decision-making (although this was before AI became so widespread and available to everybody) – I’ve come to a simple conclusion: (Click on image to see the full overview) AI is not our saviour. It’s our amplifier and our mirror. It amplifies whatever we feed into it – brilliance or bias, empathy or greed – and reflects our collective systems, values, and flaws back at us with unnerving accuracy. AI has no soul, no conscience, no intrinsic sense of “good.”  Nevertheless, I always end my prompts with “Thank You”. What it has is scale. It executes human intent – good or bad – faster, louder, and wider than ever before. So, the question isn’t just what AI will do to us.It’s what we will do with AI.And whether we have the courage, education, and moral clarity to steer it wisely, under the umbrella “responsible AI” – before it steers us. What AI Really Is – and Why That Matters Before we can talk about impact, we need to clear the fog. AI doesn’t “think.” It doesn’t “learn” like a human. It doesn’t “understand” your business, your feelings, or your cat videos. Although many users seem to believe this. There is even a disturbing trend to see AI as religion: ChatGPT Religion: The Disturbing AI Cult. What large language models (like ChatGPT) do is predict the next statistically likely word, based on trillions of examples. It’s a breathtakingly sophisticated guessing machine – I compare it to a parrot with a PhD in probability. That means AI doesn’t create truth; it recombines it. It doesn’t generate wisdom; it synthesizes what’s already out there. And since most of what’s “out there” is written by humans with blind spots, biases, and occasionally questionable judgment, those same biases are baked into every digital prediction. When you ask AI to summarize “the typical professional,” it might over-represent men. When you ask it to “suggest a good leader,” it might prefer youth. When you ask it to “write a diet plan for women,” it might use unrealistic, data-skewed health metrics. AI is biased – as are the texts it has been trained on. Unfortunately, these are not innocent errors, they are reflections of the data we’ve produced as a society. And because AI amplifies patterns, it doesn’t just mirror inequality – it multiplies it. So, when I say AI is a mirror, I mean it quite literally.The question is: do we like what we see? History Repeats – Only Faster If all this sounds familiar, it’s because we’ve been here before. Well, if you are my age, you have seen economic bubbles burst. Every industrial revolution has promised liberation and delivered disruption first. The steam engine freed us from physical labour but trapped millions in factories.The computer promised “the paperless office” and gave us inboxes overflowing with digital busywork. The pattern is always the same: early adopters profit, while ordinary people adjust, often painfully.Yes, society eventually catches up – but only after decades of inequality, policy failure, and public backlash. The Industrial Revolution generated immense wealth but concentrated it in a few hands for nearly a century. Real wages stagnated while profits soared.And now, as AI begins its own revolution, we are watching the same movie again – only in high definition. Here’s the unromantic truth: technology doesn’t automatically create fairness.It creates potential. What happens next depends on governance, education, and human decency. Without deliberate intervention, the “AI revolution” will follow the same pattern – immense wealth for a few, lost livelihoods for many, and a widening gap between those who understand the tools and those who are used by them. There are experts around, who are sure, this will happen rather sooner than later. Therefore, it is even more important, to focus on “responsible AI”: think about consequences, before blindly following a trend. The Productivity Illusion There’s a persistent fantasy that AI will finally make the economy boom – that by automating drudgery, we’ll all have time for creativity, family, or yoga retreats. Lovely idea. Unfortunately, reality isn’t playing along. Decades of data show that massive investments in technology do not automatically lead to higher productivity. Economists call it the “productivity paradox”: we see the gadgets everywhere – but not in the GDP. Why? Because plugging in new technology doesn’t automatically fix broken systems.Real productivity comes from humans – educated, healthy, motivated humans – who know how to integrate new tools into meaningful work. When companies adopt AI, they often see an initial drop in productivity before any long-term gains appear. Systems must be redesigned, staff retrained, data cleaned up – and all of that takes time and money. Most companies don’t have a strategy or plan in place, yet hope, that AI will fix a lack of clear vision. It doesn’t. The flashy dashboards might impress shareholders, but transformation only works…

AI 2.0 for women 50plus

Longevity 2.0: AI and Ageing for Women 50+

From smartwatches to “digital twins,” here’s how artificial intelligence is reshaping the way we age – and why it’s not as scary (or as magical) as it sounds. Introduction “The landscape of health and ageing is undergoing a radical transformation, with artificial intelligence (AI) emerging as a pivotal force.” That line caught my eye somewhere online, and I couldn’t help but think: Really? Many “longevity coaches” I meet can barely explain what longevity means, let alone how AI fits into it. When I first created my Longevity Course back in 2023, I used AI mostly behind the scenes, for drafting, organizing, and fact-checking. But the more I used it, the clearer it became: AI isn’t just a useful tool in the background, I am convinced, it can actively shape how we age. It can help us stay stronger, sharper, and more independent for longer. This matters especially for those of us my age, without children, and fully aware that, given demographic trends, we may have less support when we reach 80 or 90. I’m optimistic – a) I hope that I reach this age and b) and I trust AI to make that future more manageable and dignified. Fast-forward to Q4 of 2025. I finally sat down to connect all the dots and make sense of the advance features I learned during my AI certification program. AI is no longer a distant buzzword, it’s woven into daily life. Many of us already use it without noticing: our phones suggest when to leave for an appointment, our watches nudge us to stand up, and our streaming apps somehow know our mood better than our partners do. So why not use it for something really meaningful – like improving how we age? This article is part reflection, part research. It’s my attempt to sort through the good, the bad, and the slightly creepy sides of AI and longevity. My “Longevity @50plus” course covers already how AI can: All of this by using free AI tools. But let us explore what else is already possible, what’s coming soon, and what might (with a bit of luck) arrive before I’m too old to enjoy it. Part I: The AI-Powered Longevity Journey – Practical Tools Available Today These are the tools we can use right now – no lab, no white coat required. They turn complex health data into simple, actionable insights. That’s the claim. But before we dive in, a gentle word of caution (and I will talk explicitly about the risks at the end of each subchapter): Just because you can track everything doesn’t mean you should. At some point, monitoring every heartbeat, breath, and bowel movement stops improving your health and starts fuelling anxiety. For me, the constant analysis when something deviates from the norm would be maddening – 25 years in Corporate Controlling have hardwired me to chase anomalies, and that habit doesn’t always serve well in daily life. Advanced Metabolic Health in the Digital Age AI-driven apps are redefining how we understand metabolism. It seems as if we are finally moving beyond the outdated “eat less, move more” mantra (which shouldn’t be your mantra to start with). Tools like HUMANITY[i] and Longist assign you a daily “Longevity Score,” showing whether your choices are helping or harming your biological age. It’s like a report card for your life habits – if only school had been this honest. The Longist app even translates meal logs into a projected lifespan impact (a little dramatic, but effective). It’s smart enough to predict whether that late-night pizza will shorten your life or just your patience. Similarly, Purovitalis Aura tracks more than 50 biomarkers to create a full health span profile. Impressive, yes—but also a bit terrifying if you don’t know what half of those markers mean. Continuous glucose monitors (CGMs) like Dexcom G7 have also entered the mainstream, merging with AI to give real-time feedback. They can now predict blood sugar spikes, link them to your meals, and even suggest a short walk to flatten the curve. A great step forward – in this context, literally. Reality Check:Let me summarise the risks for you, before we move on: The ability to track everything doesn’t automatically lead to better health – it can easily spiral into obsession. I’ve seen women spend more time worrying about their glucose curves than enjoying their meals. And let’s not forget the price tag: sensors, subscriptions, and smart rings aren’t cheap. For many of us, that money is better spent on high-quality food, not gadgets. Finally: “democratization” of health tracking is a myth if the entry ticket costs a small fortune. Harnessing AI for Hormonal Balance Here’s where it gets good: AI tools that finally take women’s hormones seriously. No more “it’s probably stress” while your gynaecologist shrugs and glances at the clock. And if getting an appointment in under six months feels like trying to get tickets to a Beyoncé concert, AI steps in as your on-call co-pilot. Think symptom tracking without the guesswork, cycle insights that don’t treat you like a mystery, and pattern detection that spots what your calendar, your cravings, and your skin have been trying to tell you. It won’t replace a doctor, but it will help you show up with receipts: clear trends, smart questions, and fewer “wait, when did that start?” moments. The Oova App allows women to do lab-grade hormone testing at home. A simple test strip, a quick scan with your phone, and voilà: you’ll see your levels of estrogen, progesterone, and luteinizing hormone. The app turns these readings into a “Perimenopause Map,” helping you understand what’s behind your mood swings (besides your partner’s behaviour). Then there’s the Clue App, which uses AI to analyse your symptoms, moods, and patterns. It’s a solid option if you’re not ready to dive into the biochemical depths but want to connect the dots between how you feel and what your body’s doing. Both apps can generate doctor-ready reports, bridging the gap between DIY health…